Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.

× No keyword cloud information.

14 in total

1. The over-shoot phenomenon on withdrawal of clonidine therapy.

Authors: A D Goldberg; P R Wilkinson; E B Raftery
Journal: Postgrad Med J Date: 1976 Impact factor: 2.401

2. Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy.

Authors: C T Dollery
Journal: Aust N Z J Med Date: 1976-08

3. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management.

Authors: L Hansson; S N Hunyor; S Julius; S W Hoobler
Journal: Am Heart J Date: 1973-05 Impact factor: 4.749

4. Antihypertensive effect of a new imidazoline compound (clonidine) and chlorthalidone, individually and in combination.

Authors: W B Parsons; J H Morledge
Journal: Am J Cardiol Date: 1970-09 Impact factor: 2.778

5. [First experiences with BS 100-141, a new antihypertensive substance].

Authors: I Esch
Journal: Int J Clin Pharmacol Biopharm Date: 1976-09

6. Blood pressure and heart rate and withdrawal of antihypertensive drugs.

Authors: A D Goldberg; E B Raftery; P Wilkinson
Journal: Br Med J Date: 1977-05-14

7. Clonidine versus methyldopa. A double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect.

Authors: A K Amery; H Bossaert; R H Fagard; M Verstraete
Journal: Acta Cardiol Date: 1972 Impact factor: 1.718

8. Side effects of hypotensive agents evaluated by a self-administered questionnaire.

Authors: C J Bulpitt; C T Dollery
Journal: Br Med J Date: 1973-09-01

9. [Clinical and biological manifestations following the interruption of prolonged treatment with clonidine].

Authors: M O Spach; C Steimer; R Bloch
Journal: Nouv Presse Med Date: 1977-04-09

10. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.

Authors: J L Reid; L M Wing; H J Dargie; C A Hamilton; D S Davies; C T Dollery
Journal: Lancet Date: 1977-06-04 Impact factor: 79.321

8 in total

1. Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.

Authors: Yu Chen; Grazyna Palczewska; Debarshi Mustafi; Marcin Golczak; Zhiqian Dong; Osamu Sawada; Tadao Maeda; Akiko Maeda; Krzysztof Palczewski
Journal: J Clin Invest Date: 2013-11-15 Impact factor: 14.808

2. Disrupted in schizophrenia 1 modulates medial prefrontal cortex pyramidal neuron activity through cAMP regulation of transient receptor potential C and small-conductance K+ channels.

Authors: Lynda El-Hassar; Arthur A Simen; Alvaro Duque; Kiran D Patel; Leonard K Kaczmarek; Amy F T Arnsten; Mark F Yeckel
Journal: Biol Psychiatry Date: 2014-01-20 Impact factor: 13.382

Review 3. Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder.

Authors: Chao-Lin Ma; Xuan Sun; Fei Luo; Bao-Ming Li
Journal: Neurosci Bull Date: 2015-03-31 Impact factor: 5.203

4. Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure.

Authors: J R Kiechel; D Lavene; M Guerret; E Comoy; M Godin; J P Fillastre
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

5. Clinical experience with guanfacine in long-term treatment of hypertension.

Authors: P Jerie
Journal: Br J Clin Pharmacol Date: 1980 Impact factor: 4.335

6. The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.

Authors: J L Reid
Journal: Br J Clin Pharmacol Date: 1981-09 Impact factor: 4.335

7. Effects of guanabenz and guanfacine on postsynaptic alpha 2-adrenoceptors in the rat submaxillary and parotid glands.

Authors: M D Kaniucki; J C Elverdin; F J Stefano; C J Perec
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1985-05 Impact factor: 3.000

Review 8. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors: E M Sorkin; R C Heel
Journal: Drugs Date: 1986-04 Impact factor: 9.546

8 in total